CELU Insider Trading Activity and SEC Form 4 Filings
CELU insider trading summary
No open-market insider purchases or sales of Celularity Inc (CELU) have been reported on SEC Form 4 in the past 12 months.
Latest CELU insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 12, 2024 | Kok Thay Lim | Insider | Buy | $5.3M (21,410,983 @ $0.25) |
| Jan 12, 2024 | Dragasac Ltd | Insider | Buy | $5.3M (21,410,983 @ $0.25) |
| Jan 12, 2024 | Berhad Genting | Insider | Buy | $5.3M (21,410,983 @ $0.25) |
| Oct 5, 2023 | Robert J Hariri | Chief Executive Officer | Buy | $1.0M (6,307,158 @ $0.16) |
| Oct 5, 2023 | Sorrento Therapeutics, Inc. | 10% Owner | Sell | $0 (6,307,158 @ $0.00) |
| Oct 5, 2023 | Robert J Hariri | Chief Executive Officer | Buy | $484K (3,050,427 @ $0.16) |
| Sep 29, 2023 | Robert J Hariri | Chief Executive Officer | Buy | $1.5M (9,064,539 @ $0.17) |
| Sep 29, 2023 | Sorrento Therapeutics, Inc. | 10% Owner | Sell | $0 (9,064,539 @ $0.00) |
| Nov 30, 2022 | Robert J Hariri | Chief Executive Officer | Buy | $17K (10,000 @ $1.72) |
| Nov 29, 2022 | Robert J Hariri | Chief Executive Officer | Buy | $68K (40,000 @ $1.71) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.